Research Summary

My research concerns access, delivery, and organization of substance abuse treatment services. My experience in this area includes studies evaluating efforts to improve access to publicly funded drug abuse treatment, assessing federal policy to end addiction as an SSI disability category, evaluating needle exchange as an HIV prevention strategy, and investigating interventions for drug-involved offenders. In recent years, my work has focused on tobacco dependence in addictions treatment, because of the high rate of smoking in this population, because of the known health consequences, and because of the increasing evidence that quitting smoking in addictions treatment also improves drug abuse outcomes.

I recently accepted leadership of the Tobacco Control Program of the UCSF NCI-funded HDFCCC, and I program the Cancer Center’s tobacco control seminar that postdoctoral fellows attend as part of their broader training. In the past 5 years, I have led the NIDA-funded P50 Center of Excellence, in the Department of Psychiatry, dedicated to continuing and extended care models of addiction treatment. At the national level, I chair the NIH Dissemination and Implementation Research in Health (DIRH) review committee. I have a longstanding value on training the next generation of researchers. This is most apparent in our NIDA T32 postdoctoral fellowship training program in drug abuse treatment and services research, and in our more recent R25 designed to train underrepresented minority scientists in addiction treatment. In my career, I have had primary mentoring responsibilities for 16 pre and postdoctoral scholars, and for both clinical and research training.

Research Funding

  • September 30, 2013 - August 31, 2017 - Marketing, FDA communication, tobacco perceptions and use in addiction treatment, Principal Investigator. Sponsor: NIH, Sponsor Award ID: R01DA036066
  • September 1, 1997 - May 31, 2015 - Treatment for Complex Patients: Continuing and Extended Care, Principal Investigator. Sponsor: NIH/NIDA, Sponsor Award ID: P50DA009253
  • April 20, 2006 - March 31, 2012 - Organizational Change and Nicotine Dependence Treatment, Principal Investigator. Sponsor: NIH, Sponsor Award ID: R01DA020705
  • August 1, 2009 - July 31, 2011 - Impact of Core Implementation Components on Adoption, Principal Investigator. Sponsor: NIH, Sponsor Award ID: R01DA025600

Education

Washington State University, Pullman, WA, BS, 1977, Psychology
Fort Hays State University, Hays, KS, MS, 1982, Clinical Psychology
Washington State University, Pullman, WA, PhD, 1987, Clinical Psychology
University of California, San Francisco, CA, Postdoc Fellow, 1987-1988, Behavioral Medicine
University of California, San Francisco, Research Fellow, 1988-1990, AIDS Prevention Studies
University of California, Berkeley, CA, MPH, 1990, Epidemiology

Selected Publications

  1. Pagano A, Hosakote S, Kapiteni K, Straus ER, Wong J, Guydish JR Impacts of COVID-19 on residential treatment programs for substance use disorder.  View on PubMed
  2. Guydish JR, Straus ER, Le T, Gubner N, Delucchi KL Menthol cigarette use in substance use disorder treatment before and after implementation of a county-wide flavoured tobacco ban.  View on PubMed
  3. Satre DD, Palzes VA, Young-Wolff KC, Parthasarathy S, Weisner C, Guydish J, Campbell CI Healthcare utilization of individuals with substance use disorders following Affordable Care Act implementation in a California healthcare system.  View on PubMed
  4. Guydish J, Kapiteni K, Le T, Campbell B, Pinsker E, Delucchi K Tobacco use and tobacco services in California substance use treatment programs.  View on PubMed
  5. Campbell BK, Le T, Kapiteni K, Gubner NR, Guydish J Correlates of lifetime blunt/spliff use among cigarette smokers in substance use disorders treatment.  View on PubMed
  6. Martínez C, Feliu A, Castellano Y, Fu M, Fernández P, Cabrera-Jaime S, Puig-Llobet M, Galimany J, Guydish J, Fernández E Factors associated with receipt of the 5As model of brief intervention for smoking cessation among hospitalized patients.  View on PubMed
  7. Yip D, Gubner N, Le T, Williams D, Delucchi K, Guydish J Association of Medicaid Expansion and Health Insurance with Receipt of Smoking Cessation Services and Smoking Behaviors in Substance Use Disorder Treatment.  View on PubMed
  8. Guydish J, Wahleithner J, Williams D, Yip D Tobacco-free grounds implementation in California residential substance use disorder (SUD) treatment programs.  View on PubMed
  9. Martínez C, Castellano Y, Fu M, Riccobene A, Feliu A, Tigova O, Ballbè M, Anton L, Fernández P, Cabrera-Jaime S, Puig-Llobet M, Moreno C, Falcó-Pegueroles A, Galimany J, Estrada JM, Guydish J, Fernández E Patient perceptions of tobacco control after smoke-free hospital grounds legislation: Multi-center cross-sectional study.  View on PubMed
  10. Gubner NR, Williams DD, Chen E, Silven D, Tsoh JY, Guydish J, Vijayaraghavan M Recent cessation attempts and receipt of cessation services among a diverse primary care population - A mixed methods study.  View on PubMed
  11. Gubner NR, Williams DD, Le T, Garcia W, Vijayaraghavan M, Guydish J Smoking related outcomes before and after implementation of tobacco-free grounds in residential substance use disorder treatment programs.  View on PubMed
  12. Ballbè M, Martínez C, Feliu A, Torres N, Nieva G, Pinet C, Raich A, Mondon S, Barrio P, Hernández-Ribas R, Vicens J, Costa S, Vilaplana J, Alaustre L, Vilalta E, Blanch R, Subirà S, Bruguera E, Suelves JM, Guydish J, Fernández E Effectiveness of a telephone-based intervention for smoking cessation in patients with severe mental disorders: study protocol for a randomized controlled trial.  View on PubMed
  13. Guydish J, Yip D, Le T, Gubner NR, Williams DD, Delucchi KL Tobacco Cessation Services in Addiction Treatment: What Do Clients Say?  View on PubMed
  14. Campbell BK, Le T, Yip D, Griffin KB, Gubner NR, Guydish JR Sex Differences in Graphic Warning Label Ratings by Addictions Clients.  View on PubMed
  15. Campbell B, Yip D, Le T, Gubner N, Guydish J Relationship between Tobacco Use and Health-Related Quality of Life (HRQoL) among Clients in Substance Use Disorders Treatment.  View on PubMed
  16. Campbell BK, Le T, Gubner NR, Guydish J Health risk perceptions and reasons for use of tobacco products among clients in addictions treatment.  View on PubMed
  17. Pagano A, Gubner NR, Le T, Yip D, Williams D, Delucchi K, Guydish J Differences in tobacco use prevalence, behaviors, and cessation services by race/ethnicity: A survey of persons in addiction treatment.  View on PubMed
  18. Gubner NR, Pagano A, Tajima B, Guydish J A Comparison of Daily Versus Weekly Electronic Cigarette Users in Treatment for Substance Abuse.  View on PubMed
  19. Hall SM, Humfleet GL, Gasper JJ, Delucchi KL, Hersh DF, Guydish JR Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients.  View on PubMed
  20. Gubner NR, Williams DD, Pagano A, Campbell BK, Guydish J Menthol cigarette smoking among individuals in treatment for substance use disorders.  View on PubMed

Go to UCSF Profiles, powered by CTSI